BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8615175)

  • 1. The molecular biology of xenobiotic enzymes and the predisposition to idiopathic Parkinson's disease.
    Ho SL; McCann KP; Bennett P; Kapadi AL; Waring RH; Ramsden DB; Williams AC
    Adv Neurol; 1996; 69():53-60. PubMed ID: 8615175
    [No Abstract]   [Full Text] [Related]  

  • 2. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
    Bordet R; Broly F; Destée A; Libersa C
    Adv Neurol; 1996; 69():97-100. PubMed ID: 8615190
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
    Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G
    Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic polymorphisms in Parkinson's disease.
    Checkoway H; Farin FM; Costa-Mallen P; Kirchner SC; Costa LG
    Neurotoxicology; 1998; 19(4-5):635-43. PubMed ID: 9745923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver enzyme abnormalities in Parkinson's disease.
    Tanner CM
    Geriatrics; 1991 Aug; 46 Suppl 1():60-3. PubMed ID: 1894148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some aspects of interindividual variations in the metabolism of xenobiotics.
    Tamási V; Vereczkey L; Falus A; Monostory K
    Inflamm Res; 2003 Aug; 52(8):322-33. PubMed ID: 14504670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.
    Dutheil F; Beaune P; Loriot MA
    Biochimie; 2008 Mar; 90(3):426-36. PubMed ID: 17997991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):585-7. PubMed ID: 11798822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenobiotic enzyme profiles and Parkinson's disease.
    Williams A; Steventon G; Sturman S; Waring R
    Neurology; 1991 May; 41(5 Suppl 2):29-32; discussion 32-3. PubMed ID: 2041591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies in xenobiotic metabolism and Parkinson's disease.
    Ramsden DB; Parsons RB; Ho SL; Xie T; Waring RH; Williams AC
    Adv Neurol; 2001; 86():105-13. PubMed ID: 11553967
    [No Abstract]   [Full Text] [Related]  

  • 12. P450 enzymes and Parkinson's disease: the story so far.
    Riedl AG; Watts PM; Jenner P; Marsden CD
    Mov Disord; 1998 Mar; 13(2):212-20. PubMed ID: 9539332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of enzymes and receptors involved in carcinogenesis: QSARs and compact-3D.
    Lewis DF; Moereels H; Lake BG; Ioannides C; Parke DV
    Drug Metab Rev; 1994; 26(1-2):261-85. PubMed ID: 8082570
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetic variations in the metabolism of environmental toxins].
    Autrup H
    Ugeskr Laeger; 2005 May; 167(20):2173-6. PubMed ID: 15987077
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytochrome P-450 enzymes].
    Pelkonen O; Lang M; Sotaniemi E
    Duodecim; 1990; 106(7):555-62. PubMed ID: 1670212
    [No Abstract]   [Full Text] [Related]  

  • 16. Transgenic rice plants expressing human p450 genes involved in xenobiotic metabolism for phytoremediation.
    Kawahigashi H; Hirose S; Ohkawa H; Ohkawa Y
    J Mol Microbiol Biotechnol; 2008; 15(2-3):212-9. PubMed ID: 18685273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytochrome P450 enzymes in human colon.
    Bernauer U; Ellrich R; Heinrich-Hirsch B; Teubner W; Vieth B; Gundert-Remy U
    IARC Sci Publ; 2002; 156():487-9. PubMed ID: 12484239
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase.
    Hoda F; Nicholl D; Bennett P; Arranz M; Aitchison KJ; al-Chalabi A; Kunugi H; Vallada H; Leigh PN; Chaudhuri KR; Collier DA
    Biochem Biophys Res Commun; 1996 Nov; 228(3):780-4. PubMed ID: 8941353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenobiotic metabolism in brain.
    Ravindranath V; Boyd MR
    Drug Metab Rev; 1995; 27(3):419-48. PubMed ID: 8521749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.